Atlas Trials

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-D4010 in Healthy Subjects

Clinical trial NCT02575482 · COMPLETED

Trial details

NCT number
NCT02575482
Sponsor
Suven Life Sciences Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cognitive Disorders
Start date
2015-07-01
Primary completion
2016-02-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.